We are live on
!
Find out more
Immunic
IMUX
IMUX
65 hedge funds and large institutions have $56.1M invested in Immunic in 2022 Q3 according to their latest regulatory filings, with 10 funds opening new positions, 17 increasing their positions, 21 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
358% more call options, than puts
Call options by funds: $1.37M | Put options by funds: $300K
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
0.17% less ownership
Funds ownership: 5.98% → 5.81% (-0.17%)
10% less funds holding
Funds holding: 72 → 65 (-7)
11% less capital invested
Capital invested by funds: $63.4M → $56.1M (-$7.25M)
19% less repeat investments, than reductions
Existing positions increased: 17 | Existing positions reduced: 21
41% less first-time investments, than exits
New positions opened: 10 | Existing positions closed: 17
Holders
65
Holders Change
-7
Holders Change %
-9.72%
% of All Funds
1.12%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
10
Increased
17
Reduced
21
Closed
17
Calls
$1.37M
Puts
$300K
Net Calls
+$1.07M
Net Calls Change
-$30K
Top Buyers
| 1 |
GC
Gratus Capital
Atlanta,
Georgia
|
+$3.15M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$484K |
| 3 |
Walleye Capital
New York
|
+$436K |
| 4 |
Renaissance Technologies
New York
|
+$425K |
| 5 |
Verition Fund Management
Greenwich,
Connecticut
|
+$373K |
Top Sellers
| 1 |
Adage Capital Partners
Boston,
Massachusetts
|
-$2.08M |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$2.08M |
| 3 |
Janus Henderson Group
London,
United Kingdom
|
-$900K |
| 4 |
Two Sigma Investments
New York
|
-$366K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$292K |
